106 related articles for article (PubMed ID: 24315416)
1. [Delayed development of multiple supernumerary teeth in a patient with juvenile myasthenia gravis treated with azathioprine].
Varela M; García-Camba P; Gutiérrez Mosquera B; García Rosas S; Lorda I
An Pediatr (Barc); 2014 Sep; 81(3):200-1. PubMed ID: 24315416
[No Abstract] [Full Text] [Related]
2. Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia.
Finsterer J; Frank M; Krexner E
South Med J; 2010 Feb; 103(2):182-4. PubMed ID: 20065912
[No Abstract] [Full Text] [Related]
3. Immunosuppressive treatment for juvenile myasthenia gravis.
Badurska B; Ryniewicz B; Strugalska H
Eur J Pediatr; 1992 Mar; 151(3):215-7. PubMed ID: 1601015
[TBL] [Abstract][Full Text] [Related]
4. Brainstem lymphoma in a myasthenia gravis patient on azathioprine.
Termsarasab P; Katirji B
J Clin Neurosci; 2015 Feb; 22(2):415-8. PubMed ID: 25443086
[TBL] [Abstract][Full Text] [Related]
5. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.
Cosi V; Lombardi M; Erbetta A; Piccolo G
Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322
[TBL] [Abstract][Full Text] [Related]
6. The treatment of severe myasthenia gravis with immunosuppressive agents.
Mertens HG; Balzereit F; Leipert M
Eur Neurol; 1969; 2(6):321-39. PubMed ID: 4185500
[No Abstract] [Full Text] [Related]
7. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis.
Bromberg MB; Wald JJ; Forshew DA; Feldman EL; Albers JW
J Neurol Sci; 1997 Sep; 150(1):59-62. PubMed ID: 9260858
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive drugs in treatment of myasthenia gravis.
Rowland LP
Ann N Y Acad Sci; 1971 Sep; 183():351-7. PubMed ID: 5287832
[No Abstract] [Full Text] [Related]
9. Medical treatment options for ocular myasthenia gravis.
Antonio-Santos AA; Eggenberger ER
Curr Opin Ophthalmol; 2008 Nov; 19(6):468-78. PubMed ID: 18854691
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of myasthenia gravis].
Jerusalem F
Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
[No Abstract] [Full Text] [Related]
11. [Current results of the treatment of pseudoparalytic myasthenia gravis with immunosuppressive agents].
Ricken D
Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):237-41. PubMed ID: 4341360
[No Abstract] [Full Text] [Related]
12. Immunosuppressive drug therapy in myasthenia gravis.
Niakan E; Harati Y; Rolak LA
Arch Neurol; 1986 Feb; 43(2):155-6. PubMed ID: 3947257
[TBL] [Abstract][Full Text] [Related]
13. [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis].
Braun SA; Helbig D; Frank J; Hanneken S
Hautarzt; 2012 Oct; 63(10):756-9. PubMed ID: 23008007
[TBL] [Abstract][Full Text] [Related]
14. Primary CNS lymphoma in myasthenic on long-term azathioprine.
Finelli PF
J Neurooncol; 2005 Aug; 74(1):91-2. PubMed ID: 16078114
[No Abstract] [Full Text] [Related]
15. [Immunosuppressive treatment in neurological disorders].
Aarli JA
Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438
[No Abstract] [Full Text] [Related]
16. High-dose immunosuppressive therapy in generalised myasthenia gravis--a 2-year follow-up study.
Heckmann JM; LeePan EB; Eastman RW
S Afr Med J; 2001 Sep; 91(9):765-70. PubMed ID: 11680327
[TBL] [Abstract][Full Text] [Related]
17. Azathioprine therapy for acquired myasthenia gravis in five dogs.
Dewey CW; Coates JR; Ducoté JM; Meeks JC; Fradkin JM
J Am Anim Hosp Assoc; 1999; 35(5):396-402. PubMed ID: 10493415
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical analysis of acetylcholine receptor and its relevance to specific treatment of experimental autoimmune myasthenia gravis.
Fuchs S
Adv Cytopharmacol; 1979; 3():279-85. PubMed ID: 382790
[No Abstract] [Full Text] [Related]
19. Portal hypertension secondary to azathioprine in myasthenia gravis.
Fonseca V; Havard CW
Postgrad Med J; 1988 Dec; 64(758):950-2. PubMed ID: 3256814
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis in children: a longitudinal study.
Ashraf VV; Taly AB; Veerendrakumar M; Rao S
Acta Neurol Scand; 2006 Aug; 114(2):119-23. PubMed ID: 16867035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
